Cited by

• [Systemic sclerosis-clinical picture, diagnosis, and treatment].

  Becker MO, Distler O, Maurer B. Becker MO, et al. Hautarzt. 2019 Sep;70(9):723-741. doi: 10.1007/s00105-019-4454-0. Hautarzt. 2019. PMID: 31384958 German.
• Pathogenic roles of autoantibodies in systemic sclerosis: Current understandings in pathogenesis.

  Senécal JL, Hoa S, Yang R, Koenig M. Senécal JL, et al. J Scleroderma Relat Disord. 2020 Jun;5(2):103-129. doi: 10.1177/2397198319870667. Epub 2019 Sep 9. J Scleroderma Relat Disord. 2020. PMID: 35382028 Free PMC article. Review.
• Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality.

  De Almeida Chaves S, Porel T, Mounié M, Alric L, Astudillo L, Huart A, Lairez O, Michaud M, Prévot G, Ribes D, Sailler L, Gaches F, Adoue D, Pugnet G. De Almeida Chaves S, et al. Arthritis Res Ther. 2021 Dec 7;23(1):295. doi: 10.1186/s13075-021-02672-y. Arthritis Res Ther. 2021. PMID: 34876194 Free PMC article.
• Limited mouth opening secondary to diffuse systemic sclerosis.

  Wada T, Ram S. Wada T, et al. Case Rep Dent. 2013;2013:937487. doi: 10.1155/2013/937487. Epub 2013 Dec 18. Case Rep Dent. 2013. PMID: 24455325 Free PMC article.
• Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.

  Mierau R, Moinzadeh P, Riemekasten G, Melchers I, Meurer M, Reichenberger F, Buslau M, Worm M, Blank N, Hein R, Müller-Ladner U, Kuhn A, Sunderkötter C, Juche A, Pfeiffer C, Fiehn C, Sticherling M, Lehmann P, Stadler R, Schulze-Lohoff E, Seitz C, Foeldvari I, Krieg T, Genth E, Hunzelmann N. Mierau R, et al. Arthritis Res Ther. 2011;13(5):R172. doi: 10.1186/ar3495. Epub 2011 Oct 21. Arthritis Res Ther. 2011. PMID: 22018289 Free PMC article.